JPH09512165A - インターロイキン15 - Google Patents
インターロイキン15Info
- Publication number
- JPH09512165A JPH09512165A JP7526299A JP52629994A JPH09512165A JP H09512165 A JPH09512165 A JP H09512165A JP 7526299 A JP7526299 A JP 7526299A JP 52629994 A JP52629994 A JP 52629994A JP H09512165 A JPH09512165 A JP H09512165A
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- dna sequence
- host cell
- mammalian
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1994/003793 WO1995027722A1 (en) | 1994-04-06 | 1994-04-06 | Interleukin-15 |
NZ266264A NZ266264A (en) | 1994-04-06 | 1994-04-06 | Mammalian epithelium-derived t-cell factor called interleukin-15 |
ZA942636A ZA942636B (en) | 1994-04-06 | 1994-04-18 | Interleukin-15 |
OA60897A OA10375A (en) | 1994-04-06 | 1996-09-27 | Interleukin-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09512165A true JPH09512165A (ja) | 1997-12-09 |
Family
ID=33314050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7526299A Pending JPH09512165A (ja) | 1994-04-06 | 1994-04-06 | インターロイキン15 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPH09512165A (no) |
AU (1) | AU680909B2 (no) |
FI (1) | FI117054B (no) |
NO (1) | NO318435B1 (no) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010527919A (ja) * | 2007-05-11 | 2010-08-19 | アルター・バイオサイエンス・コーポレーション | 融合分子及びil−15変異体 |
JP2017509618A (ja) * | 2014-03-03 | 2017-04-06 | サイチューン・ファーマCytune Pharma | Il−15/il−15rアルファ系コンジュゲートの精製方法 |
US11046747B2 (en) | 2010-09-21 | 2021-06-29 | Altor Bioscience Llc | Multimeric IL-15 soluble fusion molecules and methods of making and using same |
US11053299B2 (en) | 2010-09-21 | 2021-07-06 | Immunity Bio, Inc. | Superkine |
WO2021200744A1 (ja) * | 2020-03-31 | 2021-10-07 | Cell Exosome Therapeutics株式会社 | 増殖細胞の生産方法、細胞生産物の生産方法、間葉系幹細胞集団およびその生産方法、幹細胞の培養上清およびその生産方法、並びに治療剤 |
US11173191B2 (en) | 2014-06-30 | 2021-11-16 | Altor BioScience, LLC. | IL-15-based molecules and methods of use thereof |
US11318201B2 (en) | 2016-10-21 | 2022-05-03 | Altor BioScience, LLC. | Multimeric IL-15-based molecules |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2986312B1 (en) | 2013-04-19 | 2021-12-15 | Cytune Pharma | Cytokine derived treatment with reduced vascular leak syndrome |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5552303A (en) * | 1993-03-08 | 1996-09-03 | Immunex Corporation | DNA encoding epithelium-derived T-cell factor |
US5574138A (en) * | 1993-03-08 | 1996-11-12 | Immunex Corporation | Epithelium-derived T-cell factor |
US5795966A (en) * | 1995-02-22 | 1998-08-18 | Immunex Corp | Antagonists of interleukin-15 |
-
1994
- 1994-04-06 JP JP7526299A patent/JPH09512165A/ja active Pending
- 1994-04-06 AU AU67673/94A patent/AU680909B2/en not_active Ceased
-
1996
- 1996-09-25 FI FI963828A patent/FI117054B/fi not_active IP Right Cessation
- 1996-09-30 NO NO19964141A patent/NO318435B1/no not_active IP Right Cessation
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11365231B2 (en) | 2007-05-11 | 2022-06-21 | Altor Bioscience, Llc | Interleukin 15 (IL-15) variants |
US8940289B2 (en) | 2007-05-11 | 2015-01-27 | Altor Bioscience Corporation | Fusion molecules and IL-15 variants |
US9464127B2 (en) | 2007-05-11 | 2016-10-11 | Altor Bioscience Corporation | Fusion molecules and IL-15 variants |
US9593152B2 (en) | 2007-05-11 | 2017-03-14 | Altor Bioscience Corporation | Methods of treating disease with fusion molecules comprising IL-15 variants |
US10450359B2 (en) | 2007-05-11 | 2019-10-22 | Altor Bioscience Corporation | IL-15 variants and uses thereof |
JP2010527919A (ja) * | 2007-05-11 | 2010-08-19 | アルター・バイオサイエンス・コーポレーション | 融合分子及びil−15変異体 |
US11673932B2 (en) | 2007-05-11 | 2023-06-13 | Altor BioScience, LLC. | Fusion molecules and IL-15 variants |
US11498950B1 (en) | 2007-05-11 | 2022-11-15 | Altor Bioscience, Llc | Fusion molecules and IL-15 variants |
US11845783B2 (en) | 2010-09-21 | 2023-12-19 | Altor BioScience, LLC. | Multimeric IL-15 soluble fusion molecules and methods of making and using same |
US11046747B2 (en) | 2010-09-21 | 2021-06-29 | Altor Bioscience Llc | Multimeric IL-15 soluble fusion molecules and methods of making and using same |
US11053299B2 (en) | 2010-09-21 | 2021-07-06 | Immunity Bio, Inc. | Superkine |
US11104716B2 (en) | 2010-09-21 | 2021-08-31 | Altor BioScience, LLC. | Multimeric IL-15 soluble fusion molecules and methods of making and using same |
JP2020063288A (ja) * | 2014-03-03 | 2020-04-23 | サイチューン ファーマ | Il−15/il−15rアルファ系コンジュゲートの精製方法 |
JP2017509618A (ja) * | 2014-03-03 | 2017-04-06 | サイチューン・ファーマCytune Pharma | Il−15/il−15rアルファ系コンジュゲートの精製方法 |
US11471511B2 (en) | 2014-06-30 | 2022-10-18 | Altor Bioscience, Llc | IL-15-based molecules and methods of use thereof |
US11173191B2 (en) | 2014-06-30 | 2021-11-16 | Altor BioScience, LLC. | IL-15-based molecules and methods of use thereof |
US11679144B2 (en) | 2014-06-30 | 2023-06-20 | Altor BioScience, LLC. | IL-15-based molecules and methods of use thereof |
US11890323B2 (en) | 2014-06-30 | 2024-02-06 | Altor Bioscience, Llc | Method of treating cancer with composition comprising IL-15-based molecules and BCG |
US11925676B2 (en) | 2014-06-30 | 2024-03-12 | Altor BioScience, LLC. | Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex |
US11992516B2 (en) | 2014-06-30 | 2024-05-28 | Altor BioScience, LLC. | Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodies |
US12097244B2 (en) | 2014-06-30 | 2024-09-24 | Altor BioScience, LLC. | Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibody |
US11318201B2 (en) | 2016-10-21 | 2022-05-03 | Altor BioScience, LLC. | Multimeric IL-15-based molecules |
US11369679B2 (en) | 2016-10-21 | 2022-06-28 | Altor Bioscience, Llc | Multimeric IL-15-based molecules |
JP2022181218A (ja) * | 2020-03-31 | 2022-12-07 | Cell Exosome Therapeutics株式会社 | 増殖細胞の生産方法、細胞生産物の生産方法、間葉系幹細胞集団およびその生産方法、幹細胞の培養上清およびその生産方法、並びに治療剤 |
WO2021200744A1 (ja) * | 2020-03-31 | 2021-10-07 | Cell Exosome Therapeutics株式会社 | 増殖細胞の生産方法、細胞生産物の生産方法、間葉系幹細胞集団およびその生産方法、幹細胞の培養上清およびその生産方法、並びに治療剤 |
Also Published As
Publication number | Publication date |
---|---|
FI117054B (fi) | 2006-05-31 |
NO964141D0 (no) | 1996-09-30 |
NO318435B1 (no) | 2005-03-21 |
NO964141L (no) | 1996-12-06 |
FI963828A0 (fi) | 1996-09-25 |
AU680909B2 (en) | 1997-08-14 |
AU6767394A (en) | 1995-10-30 |
FI963828A (fi) | 1996-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0772624B1 (en) | Interleukin-15 | |
US5552303A (en) | DNA encoding epithelium-derived T-cell factor | |
US5985262A (en) | Method of treatment with epithelium derived T-cell factor | |
AU646881B2 (en) | Adoptive immunotherapy with interleukin-7 | |
KR100607609B1 (ko) | Il-2 선택성 작용제 및 길항제 | |
US7875709B2 (en) | Nucleic acids encoding interleukin-18 mutants | |
JP2002514887A (ja) | トロンボポイエチンポリペプチドの分泌方法 | |
FI103987B (fi) | Interleukiini-7 | |
KR100496460B1 (ko) | 폴리펩티드 | |
AU2002324249A1 (en) | Interleukin-18 mutants, their production and use | |
JPH09512165A (ja) | インターロイキン15 | |
AU620537B2 (en) | Human interleukin-4 muteins | |
US20080090762A1 (en) | Epithelum-derived T-cell factor | |
JP3689111B2 (ja) | インターロイキン15 | |
Devereux et al. | Granulocyte-macrophage colony-stimulating factor |